A Simple Task Becomes Dangerous
Imagine standing up from a chair to get a glass of water. For most of us, it’s automatic. But for someone with Multiple System Atrophy (MSA), that simple motion can cause a sudden drop in blood pressure. The room spins. Vision blurs. They might faint.
This condition is called neurogenic orthostatic hypotension (nOH). It’s a hallmark of MSA, a rare brain disorder that affects movement and automatic body functions. But a new real-world survey shows that this dangerous symptom is often missed or poorly managed, leaving patients housebound and dependent on others.
MSA is a progressive disease that attacks the parts of the brain controlling balance, blood pressure, and bladder function. It affects roughly 15,000 to 50,000 people in the United States. There is no cure.
The most disabling symptom for many is nOH—a sudden drop in blood pressure when standing. This isn’t just dizziness. It can cause falls, blackouts, and severe fatigue. Patients often stop doing simple things like bathing or cooking because they’re afraid of collapsing.
Current treatments include medications that raise blood pressure and lifestyle changes like drinking more water. But this study suggests the real-world problem is much bigger than doctors realize.
The Gap Between Diagnosis and Reality
In the past, doctors focused mostly on the movement symptoms of MSA, like tremors or stiffness. Blood pressure issues were often seen as a side note.
But here’s the twist: this survey of 259 MSA patients shows that nOH is the central problem for daily life. Over 40% of patients had symptoms highly suspicious of nOH but no formal diagnosis. Another 21% had never had their blood pressure measured while standing during a clinic visit.
That means many patients are walking—or falling—through life with a treatable condition that no one has checked for.
How Blood Pressure Control Fails
Think of your body’s blood pressure system like a home thermostat. When you stand up, gravity pulls blood downward. A healthy system instantly adjusts—tightening blood vessels and slightly increasing heart rate—to keep enough blood flowing to the brain.
In MSA, that thermostat is broken. The brain can’t send the right signals to tighten vessels. Blood pools in the legs, and the brain gets less oxygen. That’s when dizziness hits.
Medications called pressor agents act like a manual override. They force blood vessels to tighten. But this study found that even with these drugs, 97% of patients still had major limits in daily activities.
Researchers analyzed responses from 259 adults with self-reported MSA. The average age was 64. About 44% were women.
Key findings:
- 42% had a confirmed nOH diagnosis.
- 40% had clear symptoms but no diagnosis.
- 21% had never had a standing blood pressure check.
The study also found a clear pattern: the more nOH symptoms a patient had, the more likely they needed medication. Each additional symptom increased the odds of needing a pressor drug by 18%.
But here’s the sobering part: despite treatment, nearly all patients reported major limits. 97% struggled with bathing, cooking, or getting out of bed. Three-quarters needed a caregiver to help with daily tasks because their blood pressure drops weren’t fully controlled.
The Real-World Impact
This isn’t just about numbers. It’s about quality of life.
When nOH is untreated, patients become isolated. They avoid leaving home. They stop hobbies. They rely on family for basic needs. This study shows that even when patients are on medication, the problem persists.
This doesn’t mean current treatments are useless. It means they’re often not enough on their own.
Where This Fits In
Experts have long known that nOH is common in MSA. But this study is one of the first to capture the burden from the patient’s perspective in a large community sample. It shows a clear gap between what patients experience and what clinical care addresses.
The takeaway: doctors need to screen for nOH more aggressively in MSA patients, and treatments need to go beyond just prescribing pills.
If you or a loved one has MSA and struggles with dizziness, fatigue, or falls when standing, ask your doctor about a standing blood pressure test. It’s simple: measure blood pressure while lying down, then again after standing for 1 and 3 minutes.
This study suggests that many patients are undertreated. Adjusting medication, adding compression stockings, or increasing fluid intake might help. But always talk to your doctor before changing treatment.
This was a survey study based on self-reported diagnoses. It can’t prove cause and effect. The sample, while large for a rare disease, may not represent all MSA patients. Also, the data comes from an online survey, which might miss the most severely ill patients who can’t access the internet.
The researchers hope this data will push for better screening and more effective treatments. Future trials should test combination therapies—medication plus lifestyle changes—to see if they can reduce caregiver dependence and improve daily function.
For now, the message is clear: nOH in MSA is underrecognized and undertreated. Better awareness and proactive care could make a real difference in patients’ lives.